Claims
- 1. 3-[4-(4-Phenyl-1,2,3,6-tetrahydro-1-pyridyl)-butyl]-5-hydroxy-indole methanesulfonate (I).
- 2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- 3. A pharmaceutical composition of claim 2 containing 0.2 to 2 mg of said compound.
- 4. A method of achieving a sedating effect comprising administering the compound of claim 1.
- 5. A method of treating Parkinsonism comprising administering a compound of claim 1.
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. National Phase of PCT/EP87/00518, filed Sept. 12, 1987, and is a divisional of U.S. Ser. No. 907,909, filed Sept. 16, 1986 (now U.S. Pat. No. 4,711,983), which is a continuation-in-part of U.S. Ser. No. 738,329, filed May 28, 1985.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/EP87/00518 |
9/12/1987 |
|
|
5/16/1988 |
5/16/1988 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO88/01998 |
3/24/1988 |
|
|
US Referenced Citations (3)
Number |
Name |
Date |
Kind |
4131680 |
Archibald et al. |
Dec 1978 |
|
4238215 |
Zenitz |
Mar 1966 |
|
4251538 |
Hausberg et al. |
Feb 1981 |
|
Divisions (1)
|
Number |
Date |
Country |
Parent |
907909 |
Sep 1986 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
738329 |
May 1985 |
|